LIFT Trial Shows 8.1-Point Drop in Financial Toxicity Scores for Screened Cancer Patients
A North Carolina multi-site trial of the LIFT financial navigation program produced clinically meaningful reductions in financial toxicity and psychological distress among screened cancer patients. Benefits were observed regardless of rurality or insurance. Larger randomized studies with longer follow-up are required to confirm durability and downstream clinical effects.
The single-arm trial screened adults at rural and non-rural practices using the FACIT-COST instrument; only those positive for toxicity received an initial 45- to 60-minute intake followed by one to seven check-ins to identify aid programs, submit applications, and track outcomes. Post-intervention FACIT-COST scores improved by 8.1 points while secondary measures showed reductions in depression and anxiety symptoms; benefits were consistent across rural residence and insurance status. Nearly half of U.S. cancer survivors report cancer-related financial problems, with prior observational data from the Carolina Breast Cancer Study and CDC-funded networks showing amplified effects among Black women and rural residents. The LIFT results demonstrate that targeted navigation can address a modifiable driver of treatment non-adherence, yet the absence of a control arm and short follow-up leave open questions about sustained adherence and cost offsets.
VITALIS: Within 36 months, at least two additional multi-site RCTs will report mean FACIT-COST improvements of 6+ points with LIFT-style navigation in insured populations outside the Southeast.
Sources (2)
- [1]Primary Source(https://ascopubs.org/doi/10.1200/JCO.24.01234)
- [2]Supporting Source(https://www.cdc.gov/cancer/ncccp/pdf/Financial-Toxicity-Brief.pdf)